» Articles » PMID: 21079770

Contraceptive Use and Method Preference Among Women in Soweto, South Africa: the Influence of Expanding Access to HIV Care and Treatment Services

Overview
Journal PLoS One
Date 2010 Nov 17
PMID 21079770
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Preventing unintended pregnancy among HIV-positive women constitutes a critical and cost-effective approach to primary prevention of mother-to-child transmission of HIV and is a global public health priority for addressing the desperate state of maternal and child health in HIV hyper-endemic settings. We sought to investigate whether the prevalence of contraceptive use and method preferences varied by HIV status and receipt of highly active antiretroviral therapy (HAART) among women in Soweto, South Africa.

Methods: We used survey data from 563 sexually active, non-pregnant women (18-44 years) recruited from the Perinatal HIV Research Unit in Soweto (May-December, 2007); 171 women were HIV-positive and receiving HAART (median duration of use = 31 months; IQR = 28, 33), 178 were HIV-positive and HAART-naïve, and 214 were HIV-negative. Medical record review was conducted to confirm HIV status and clinical variables. Logistic regression models estimated adjusted associations between HIV status, receipt of HAART, and contraceptive use.

Results: Overall, 78% of women reported using contraception, with significant variation by HIV status: 86% of HAART users, 82% of HAART-naïve women, and 69% of HIV-negative women (p<0.0001). In adjusted models, compared with HIV-negative women, women receiving HAART were significantly more likely to use contraception while HAART-naïve women were non-significantly more likely (AOR: 2.40; 95% CI: 1.25, 4.62 and AOR: 1.59; 95% CI: 0.88, 2.85; respectively). Among HIV-positive women, HAART users were non-significantly more likely to use contraception compared with HAART-naïve women (AOR: 1.55; 95% CI: 0.84, 2.88). Similar patterns held for specific use of barrier (primarily male condoms), permanent, and dual protection contraceptive methods.

Conclusion: Among HIV-positive women receiving HAART, the observed higher prevalence of contraceptive use overall and condoms in particular promises to yield fewer unintended pregnancies and reduced risks of vertical and sexual HIV transmission. These findings highlight the potential of integrated HIV and reproductive health services to positively impact maternal, partner, and child health.

Citing Articles

A subnational socioeconomic assessment of family planning levels, projections, and disparities among married women of reproductive age in Cameroon.

Nsashiyi R, Rahman M, Ndam L, Hashizume M PLoS One. 2025; 20(2):e0318650.

PMID: 39951405 PMC: 11828404. DOI: 10.1371/journal.pone.0318650.


Utilization of modern contraception and determinants among HIV positive women in Ethiopia: a systematic review and meta-analysis.

Boke M, Geremew A, Atnafu A, Kassaw M, Haile T BMC Womens Health. 2024; 24(1):616.

PMID: 39567937 PMC: 11577708. DOI: 10.1186/s12905-024-03454-9.


Contraceptive use and associated factors among women of reproductive age on antiretroviral therapy in Awabel Woreda health centers, Northwest Ethiopia.

Amsalu M, Worku K, Ayalew M, Alamneh A SAGE Open Med. 2023; 11:20503121231190275.

PMID: 38020801 PMC: 10640806. DOI: 10.1177/20503121231190275.


Disease awareness and healthcare utilization in rural South Africa: a comparative analysis of HIV and diabetes in the HAALSI cohort.

Beidelman E, Barnighausen T, Wing C, Tollman S, Phillips M, Rosenberg M BMC Public Health. 2023; 23(1):2202.

PMID: 37940928 PMC: 10634006. DOI: 10.1186/s12889-023-17043-2.


Contraception and intersection with HIV services in 11 high HIV burden sub-Saharan African countries: Results from the population-based HIV Impact Assessment cross-sectional studies conducted from 2015 to 2018.

Solmo C, Yuengling K, Cooney M, Sachathep K, Ayton S, Phillip N Int J Gynaecol Obstet. 2023; 163(3):875-887.

PMID: 37392010 PMC: 11009789. DOI: 10.1002/ijgo.14960.


References
1.
Hogg R, Yip B, Chan K, Wood E, Craib K, OShaughnessy M . Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001; 286(20):2568-77. DOI: 10.1001/jama.286.20.2568. View

2.
Hogg R, OShaughnessy M, Gataric N, Yip B, Craib K, Schechter M . Decline in deaths from AIDS due to new antiretrovirals. Lancet. 1997; 349(9061):1294. DOI: 10.1016/S0140-6736(05)62505-6. View

3.
Cooper E, Charurat M, Mofenson L, Hanson I, Pitt J, Diaz C . Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002; 29(5):484-94. DOI: 10.1097/00126334-200204150-00009. View

4.
Wilcher R, Cates Jr W, Gregson S . Family planning and HIV: strange bedfellows no longer. AIDS. 2010; 23 Suppl 1:S1-6. PMC: 3516801. DOI: 10.1097/01.aids.0000363772.45635.35. View

5.
Baeten J, Lavreys L, Overbaugh J . The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis. 2007; 45(3):360-9. DOI: 10.1086/519432. View